Report Overview:
Immuno-oncology therapy is a type of cancer treatment that harnesses the body's immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The Global Immuno-oncology Therapy Market Size was estimated at USD 1268.69 million in 2023 and is projected to reach USD 1652.16 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Immuno-oncology Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-oncology Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-oncology Therapy market in any manner.
Global Immuno-oncology Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Market Segmentation (by Type)
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Center
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Immuno-oncology Therapy Market
? Overview of the regional outlook of the Immuno-oncology Therapy Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-oncology Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno-oncology Therapy
1.2 Key Market Segments
1.2.1 Immuno-oncology Therapy Segment by Type
1.2.2 Immuno-oncology Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno-oncology Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno-oncology Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immuno-oncology Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno-oncology Therapy Market Competitive Landscape
3.1 Global Immuno-oncology Therapy Sales by Manufacturers (2019-2024)
3.2 Global Immuno-oncology Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno-oncology Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immuno-oncology Therapy Sales Sites, Area Served, Product Type
3.6 Immuno-oncology Therapy Market Competitive Situation and Trends
3.6.1 Immuno-oncology Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno-oncology Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immuno-oncology Therapy Industry Chain Analysis
4.1 Immuno-oncology Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno-oncology Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immuno-oncology Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-oncology Therapy Sales Market Share by Type (2019-2024)
6.3 Global Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Immuno-oncology Therapy Price by Type (2019-2024)
7 Immuno-oncology Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-oncology Therapy Market Sales by Application (2019-2024)
7.3 Global Immuno-oncology Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Immuno-oncology Therapy Sales Growth Rate by Application (2019-2024)
8 Immuno-oncology Therapy Market Segmentation by Region
8.1 Global Immuno-oncology Therapy Sales by Region
8.1.1 Global Immuno-oncology Therapy Sales by Region
8.1.2 Global Immuno-oncology Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno-oncology Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno-oncology Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno-oncology Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno-oncology Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno-oncology Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen
9.1.1 Amgen Immuno-oncology Therapy Basic Information
9.1.2 Amgen Immuno-oncology Therapy Product Overview
9.1.3 Amgen Immuno-oncology Therapy Product Market Performance
9.1.4 Amgen Business Overview
9.1.5 Amgen Immuno-oncology Therapy SWOT Analysis
9.1.6 Amgen Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Immuno-oncology Therapy Basic Information
9.2.2 AstraZeneca Immuno-oncology Therapy Product Overview
9.2.3 AstraZeneca Immuno-oncology Therapy Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Immuno-oncology Therapy SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb Immuno-oncology Therapy Basic Information
9.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
9.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product Market Performance
9.3.4 Bristol-Myers Squibb Immuno-oncology Therapy SWOT Analysis
9.3.5 Bristol-Myers Squibb Business Overview
9.3.6 Bristol-Myers Squibb Recent Developments
9.4 Eli-Lilly
9.4.1 Eli-Lilly Immuno-oncology Therapy Basic Information
9.4.2 Eli-Lilly Immuno-oncology Therapy Product Overview
9.4.3 Eli-Lilly Immuno-oncology Therapy Product Market Performance
9.4.4 Eli-Lilly Business Overview
9.4.5 Eli-Lilly Recent Developments
9.5 Roche
9.5.1 Roche Immuno-oncology Therapy Basic Information
9.5.2 Roche Immuno-oncology Therapy Product Overview
9.5.3 Roche Immuno-oncology Therapy Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Immuno-oncology Therapy Basic Information
9.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Overview
9.6.3 GlaxoSmithKline Immuno-oncology Therapy Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Janssen Biotech
9.7.1 Janssen Biotech Immuno-oncology Therapy Basic Information
9.7.2 Janssen Biotech Immuno-oncology Therapy Product Overview
9.7.3 Janssen Biotech Immuno-oncology Therapy Product Market Performance
9.7.4 Janssen Biotech Business Overview
9.7.5 Janssen Biotech Recent Developments
9.8 Merck
9.8.1 Merck Immuno-oncology Therapy Basic Information
9.8.2 Merck Immuno-oncology Therapy Product Overview
9.8.3 Merck Immuno-oncology Therapy Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 Novartis
9.9.1 Novartis Immuno-oncology Therapy Basic Information
9.9.2 Novartis Immuno-oncology Therapy Product Overview
9.9.3 Novartis Immuno-oncology Therapy Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Pfizer
9.10.1 Pfizer Immuno-oncology Therapy Basic Information
9.10.2 Pfizer Immuno-oncology Therapy Product Overview
9.10.3 Pfizer Immuno-oncology Therapy Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
9.11 Sanofi
9.11.1 Sanofi Immuno-oncology Therapy Basic Information
9.11.2 Sanofi Immuno-oncology Therapy Product Overview
9.11.3 Sanofi Immuno-oncology Therapy Product Market Performance
9.11.4 Sanofi Business Overview
9.11.5 Sanofi Recent Developments
9.12 Spectrum Pharmaceuticals
9.12.1 Spectrum Pharmaceuticals Immuno-oncology Therapy Basic Information
9.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
9.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Market Performance
9.12.4 Spectrum Pharmaceuticals Business Overview
9.12.5 Spectrum Pharmaceuticals Recent Developments
9.13 Takeda
9.13.1 Takeda Immuno-oncology Therapy Basic Information
9.13.2 Takeda Immuno-oncology Therapy Product Overview
9.13.3 Takeda Immuno-oncology Therapy Product Market Performance
9.13.4 Takeda Business Overview
9.13.5 Takeda Recent Developments
9.14 BioNTech SE
9.14.1 BioNTech SE Immuno-oncology Therapy Basic Information
9.14.2 BioNTech SE Immuno-oncology Therapy Product Overview
9.14.3 BioNTech SE Immuno-oncology Therapy Product Market Performance
9.14.4 BioNTech SE Business Overview
9.14.5 BioNTech SE Recent Developments
9.15 Allogene Therapeutics
9.15.1 Allogene Therapeutics Immuno-oncology Therapy Basic Information
9.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Overview
9.15.3 Allogene Therapeutics Immuno-oncology Therapy Product Market Performance
9.15.4 Allogene Therapeutics Business Overview
9.15.5 Allogene Therapeutics Recent Developments
9.16 IMAB-I-Mab Biopharma Co., Ltd.
9.16.1 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Basic Information
9.16.2 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Overview
9.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Market Performance
9.16.4 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
9.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
9.17 Arcus Biosciences
9.17.1 Arcus Biosciences Immuno-oncology Therapy Basic Information
9.17.2 Arcus Biosciences Immuno-oncology Therapy Product Overview
9.17.3 Arcus Biosciences Immuno-oncology Therapy Product Market Performance
9.17.4 Arcus Biosciences Business Overview
9.17.5 Arcus Biosciences Recent Developments
9.18 Gritstone Oncology
9.18.1 Gritstone Oncology Immuno-oncology Therapy Basic Information
9.18.2 Gritstone Oncology Immuno-oncology Therapy Product Overview
9.18.3 Gritstone Oncology Immuno-oncology Therapy Product Market Performance
9.18.4 Gritstone Oncology Business Overview
9.18.5 Gritstone Oncology Recent Developments
9.19 Autolus Therapeutics
9.19.1 Autolus Therapeutics Immuno-oncology Therapy Basic Information
9.19.2 Autolus Therapeutics Immuno-oncology Therapy Product Overview
9.19.3 Autolus Therapeutics Immuno-oncology Therapy Product Market Performance
9.19.4 Autolus Therapeutics Business Overview
9.19.5 Autolus Therapeutics Recent Developments
9.20 Rubius Therapeutics
9.20.1 Rubius Therapeutics Immuno-oncology Therapy Basic Information
9.20.2 Rubius Therapeutics Immuno-oncology Therapy Product Overview
9.20.3 Rubius Therapeutics Immuno-oncology Therapy Product Market Performance
9.20.4 Rubius Therapeutics Business Overview
9.20.5 Rubius Therapeutics Recent Developments
10 Immuno-oncology Therapy Market Forecast by Region
10.1 Global Immuno-oncology Therapy Market Size Forecast
10.2 Global Immuno-oncology Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immuno-oncology Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region
10.2.4 South America Immuno-oncology Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immuno-oncology Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Immuno-oncology Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immuno-oncology Therapy by Type (2025-2030)
11.1.2 Global Immuno-oncology Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immuno-oncology Therapy by Type (2025-2030)
11.2 Global Immuno-oncology Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Immuno-oncology Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Immuno-oncology Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immuno-oncology Therapy Market Size Comparison by Region (M USD)
Table 5. Global Immuno-oncology Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Immuno-oncology Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Immuno-oncology Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Immuno-oncology Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2022)
Table 10. Global Market Immuno-oncology Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Immuno-oncology Therapy Sales Sites and Area Served
Table 12. Manufacturers Immuno-oncology Therapy Product Type
Table 13. Global Immuno-oncology Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immuno-oncology Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immuno-oncology Therapy Market Challenges
Table 22. Global Immuno-oncology Therapy Sales by Type (Kilotons)
Table 23. Global Immuno-oncology Therapy Market Size by Type (M USD)
Table 24. Global Immuno-oncology Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Immuno-oncology Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Immuno-oncology Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Immuno-oncology Therapy Market Size Share by Type (2019-2024)
Table 28. Global Immuno-oncology Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Immuno-oncology Therapy Sales (Kilotons) by Application
Table 30. Global Immuno-oncology Therapy Market Size by Application
Table 31. Global Immuno-oncology Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Immuno-oncology Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Immuno-oncology Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Immuno-oncology Therapy Market Share by Application (2019-2024)
Table 35. Global Immuno-oncology Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Immuno-oncology Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Immuno-oncology Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Immuno-oncology Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Immuno-oncology Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Immuno-oncology Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Immuno-oncology Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Immuno-oncology Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Amgen Immuno-oncology Therapy Basic Information
Table 44. Amgen Immuno-oncology Therapy Product Overview
Table 45. Amgen Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Amgen Business Overview
Table 47. Amgen Immuno-oncology Therapy SWOT Analysis
Table 48. Amgen Recent Developments
Table 49. AstraZeneca Immuno-oncology Therapy Basic Information
Table 50. AstraZeneca Immuno-oncology Therapy Product Overview
Table 51. AstraZeneca Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Immuno-oncology Therapy SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. Bristol-Myers Squibb Immuno-oncology Therapy Basic Information
Table 56. Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
Table 57. Bristol-Myers Squibb Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bristol-Myers Squibb Immuno-oncology Therapy SWOT Analysis
Table 59. Bristol-Myers Squibb Business Overview
Table 60. Bristol-Myers Squibb Recent Developments
Table 61. Eli-Lilly Immuno-oncology Therapy Basic Information
Table 62. Eli-Lilly Immuno-oncology Therapy Product Overview
Table 63. Eli-Lilly Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Eli-Lilly Business Overview
Table 65. Eli-Lilly Recent Developments
Table 66. Roche Immuno-oncology Therapy Basic Information
Table 67. Roche Immuno-oncology Therapy Product Overview
Table 68. Roche Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. GlaxoSmithKline Immuno-oncology Therapy Basic Information
Table 72. GlaxoSmithKline Immuno-oncology Therapy Product Overview
Table 73. GlaxoSmithKline Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Janssen Biotech Immuno-oncology Therapy Basic Information
Table 77. Janssen Biotech Immuno-oncology Therapy Product Overview
Table 78. Janssen Biotech Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Janssen Biotech Business Overview
Table 80. Janssen Biotech Recent Developments
Table 81. Merck Immuno-oncology Therapy Basic Information
Table 82. Merck Immuno-oncology Therapy Product Overview
Table 83. Merck Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Merck Business Overview
Table 85. Merck Recent Developments
Table 86. Novartis Immuno-oncology Therapy Basic Information
Table 87. Novartis Immuno-oncology Therapy Product Overview
Table 88. Novartis Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Novartis Business Overview
Table 90. Novartis Recent Developments
Table 91. Pfizer Immuno-oncology Therapy Basic Information
Table 92. Pfizer Immuno-oncology Therapy Product Overview
Table 93. Pfizer Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Pfizer Business Overview
Table 95. Pfizer Recent Developments
Table 96. Sanofi Immuno-oncology Therapy Basic Information
Table 97. Sanofi Immuno-oncology Therapy Product Overview
Table 98. Sanofi Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sanofi Business Overview
Table 100. Sanofi Recent Developments
Table 101. Spectrum Pharmaceuticals Immuno-oncology Therapy Basic Information
Table 102. Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
Table 103. Spectrum Pharmaceuticals Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Spectrum Pharmaceuticals Business Overview
Table 105. Spectrum Pharmaceuticals Recent Developments
Table 106. Takeda Immuno-oncology Therapy Basic Information
Table 107. Takeda Immuno-oncology Therapy Product Overview
Table 108. Takeda Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Takeda Business Overview
Table 110. Takeda Recent Developments
Table 111. BioNTech SE Immuno-oncology Therapy Basic Information
Table 112. BioNTech SE Immuno-oncology Therapy Product Overview
Table 113. BioNTech SE Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. BioNTech SE Business Overview
Table 115. BioNTech SE Recent Developments
Table 116. Allogene Therapeutics Immuno-oncology Therapy Basic Information
Table 117. Allogene Therapeutics Immuno-oncology Therapy Product Overview
Table 118. Allogene Therapeutics Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Allogene Therapeutics Business Overview
Table 120. Allogene Therapeutics Recent Developments
Table 121. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Basic Information
Table 122. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Overview
Table 123. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. IMAB-I-Mab Biopharma Co., Ltd. Business Overview
Table 125. IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
Table 126. Arcus Biosciences Immuno-oncology Therapy Basic Information
Table 127. Arcus Biosciences Immuno-oncology Therapy Product Overview
Table 128. Arcus Biosciences Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Arcus Biosciences Business Overview
Table 130. Arcus Biosciences Recent Developments
Table 131. Gritstone Oncology Immuno-oncology Therapy Basic Information
Table 132. Gritstone Oncology Immuno-oncology Therapy Product Overview
Table 133. Gritstone Oncology Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Gritstone Oncology Business Overview
Table 135. Gritstone Oncology Recent Developments
Table 136. Autolus Therapeutics Immuno-oncology Therapy Basic Information
Table 137. Autolus Therapeutics Immuno-oncology Therapy Product Overview
Table 138. Autolus Therapeutics Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Autolus Therapeutics Business Overview
Table 140. Autolus Therapeutics Recent Developments
Table 141. Rubius Therapeutics Immuno-oncology Therapy Basic Information
Table 142. Rubius Therapeutics Immuno-oncology Therapy Product Overview
Table 143. Rubius Therapeutics Immuno-oncology Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Rubius Therapeutics Business Overview
Table 145. Rubius Therapeutics Recent Developments
Table 146. Global Immuno-oncology Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Immuno-oncology Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Immuno-oncology Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Immuno-oncology Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Immuno-oncology Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Immuno-oncology Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Immuno-oncology Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Immuno-oncology Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Immuno-oncology Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Immuno-oncology Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Immuno-oncology Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Immuno-oncology Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Immuno-oncology Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Immuno-oncology Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Immuno-oncology Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Immuno-oncology Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Immuno-oncology Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno-oncology Therapy Market Size (M USD), 2019-2030
Figure 5. Global Immuno-oncology Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Immuno-oncology Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno-oncology Therapy Market Size by Country (M USD)
Figure 11. Immuno-oncology Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Immuno-oncology Therapy Revenue Share by Manufacturers in 2023
Figure 13. Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immuno-oncology Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immuno-oncology Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immuno-oncology Therapy Market Share by Type
Figure 18. Sales Market Share of Immuno-oncology Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Immuno-oncology Therapy by Type in 2023
Figure 20. Market Size Share of Immuno-oncology Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Immuno-oncology Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immuno-oncology Therapy Market Share by Application
Figure 24. Global Immuno-oncology Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Immuno-oncology Therapy Sales Market Share by Application in 2023
Figure 26. Global Immuno-oncology Therapy Market Share by Application (2019-2024)
Figure 27. Global Immuno-oncology Therapy Market Share by Application in 2023
Figure 28. Global Immuno-oncology Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Immuno-oncology Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Immuno-oncology Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Immuno-oncology Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Immuno-oncology Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Immuno-oncology Therapy Sales Market Share by Country in 2023
Figure 37. Germany Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Immuno-oncology Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Immuno-oncology Therapy Sales Market Share by Region in 2023
Figure 44. China Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Immuno-oncology Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Immuno-oncology Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Immuno-oncology Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Immuno-oncology Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Immuno-oncology Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Immuno-oncology Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Immuno-oncology Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Immuno-oncology Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Immuno-oncology Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Immuno-oncology Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Immuno-oncology Therapy Market Share Forecast by Application (2025-2030)
